Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-065492

Director bought 15,000 shares at an average $4.27 ($64,024)

From the SEC's structured data for this filing

Trades in this filing

CITRON JOEL TOMAS · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2006-11-21 Purchase : show line 1 in the form +100 $4.12 $412 311,077 D
2006-11-21 Purchase : show line 2 in the form +1,400 $4.13 $5,782 312,477 D
2006-11-21 Purchase : show line 3 in the form +300 $4.14 $1,242 312,777 D
2006-11-21 Purchase : show line 4 in the form +1,200 $4.15 $4,980 313,977 D
2006-11-21 Purchase : show line 5 in the form +1,540 $4.17 $6,422 315,517 D
2006-11-22 Purchase : show line 6 in the form +60 $4.31 $259 315,577 D
2006-11-22 Purchase : show line 7 in the form +10,400 $4.32 $44,928 325,977 D
Open-market purchases · 15,000 sh · avg $4.27 · $64,024
Loading xslF345X02/rrd137252.xml…